AU2003271442A1 - Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof - Google Patents

Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof

Info

Publication number
AU2003271442A1
AU2003271442A1 AU2003271442A AU2003271442A AU2003271442A1 AU 2003271442 A1 AU2003271442 A1 AU 2003271442A1 AU 2003271442 A AU2003271442 A AU 2003271442A AU 2003271442 A AU2003271442 A AU 2003271442A AU 2003271442 A1 AU2003271442 A1 AU 2003271442A1
Authority
AU
Australia
Prior art keywords
diseases
regulation
prevention
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003271442A
Inventor
John Charles Davidson
Alan Fergusson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003271442A1 publication Critical patent/AU2003271442A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003271442A 2002-10-16 2003-09-24 Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof Abandoned AU2003271442A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002407429A CA2407429C (en) 2002-10-16 2002-10-16 Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof
CA2,407,429 2002-10-16
PCT/CA2003/001451 WO2004035059A1 (en) 2002-10-16 2003-09-24 Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof

Publications (1)

Publication Number Publication Date
AU2003271442A1 true AU2003271442A1 (en) 2004-05-04

Family

ID=32097366

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003271442A Abandoned AU2003271442A1 (en) 2002-10-16 2003-09-24 Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof

Country Status (3)

Country Link
AU (1) AU2003271442A1 (en)
CA (1) CA2407429C (en)
WO (1) WO2004035059A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ526098A (en) * 2003-05-23 2005-10-28 Enzo Nutraceuticals Ltd Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine
IT201600093768A1 (en) * 2016-09-19 2018-03-19 Codex V Srl UNSAPONIFYABLE OF NATURAL LIPIDS FOR USE IN THE TREATMENT OF INFECTIOUS PATHOLOGIES AND PERIPHERAL NEUROPATHIES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197309B1 (en) * 1998-08-03 2001-03-06 Ronald E. Wheeler Prostate formula
CU22846A1 (en) * 1998-12-29 2003-04-28 Ct De Quimica Farmaceutica PHARMACEUTICAL AND NUTRITIONAL COMPOSITIONS FROM EXTRACTS OF MANGIFERA INDICA L
US6743450B2 (en) * 2000-04-14 2004-06-01 Mars, Incorporated Extraction of sterols from cocoa hulls

Also Published As

Publication number Publication date
CA2407429C (en) 2007-02-20
WO2004035059A1 (en) 2004-04-29
CA2407429A1 (en) 2004-04-16

Similar Documents

Publication Publication Date Title
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004041170A9 (en) Compositions and methods for the treatment of immune related diseases
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
EP1572116A4 (en) Compositions and methods for the treatment of immune related diseases
EP1576137A4 (en) Compositions and methods for the treatment of immune related diseases
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
EP1560593A4 (en) Novel composition and methods for the treatment of immune related diseases
IL169338A0 (en) Therapeutic formulations for the treatment of beta-amyloid related diseases
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
AU2003278775A8 (en) Porifera-based therapeutic compositions for treating and preventing skin diseases
AU2003216592A8 (en) Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
EP1578373A4 (en) Novel compositions and methods for the treatment of immune related diseases
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
HUP0104963A3 (en) Compositions for the treatment of skin diseases
WO2004024076A8 (en) Novel compositions and methods for the treatment of immune related diseases
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
EP1472273A4 (en) Compositions and methods for the treatment of immune related diseases
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
EP1539100A4 (en) Composition and methods for the treatment of skin disorders
AU2003271442A1 (en) Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase